Internal Medicine, Medical Oncology · Dallas, TX
NPI
1871535823
Since 2006
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
3410 Worth St Ste 300
Dallas, TX, 75246
Phone (214) 370-1513
Groups this clinician bills Medicare through
Medicare paid, 2024
$4.4M
186,361 services
Medicare patients, 2024
291
Average age 71
Drug cost, 2024
$6.7M
4,173 prescriptions
Company payments, 2025
$21K
From 29 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Robert B Berryman was code Q5110 (injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram), 27,420 times for 20 patients. In total Robert B Berryman billed 186,361 services in 156 codes, and Medicare paid $4.4M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-09-22.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| Q5110 Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram | Office | 27,420 | 20 | $0.22 | $6,104 |
| J1568 Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | Office | 21,650 | 69 | $36.63 | $793K |
| J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj | Office | 17,460 | 13 | $38.21 | $667K |
| J9145 Injection, daratumumab, 10 mg | Office | 15,180 | 15 | $49.39 | $750K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,987 | 26 | $0.09 | $174 |
| 36415 Venipuncture Blood Collection | Office | 1,585 | 210 | $8.65 | $14K |
| 83521 Immunoassay | Office | 1,584 | 104 | $16.92 | $27K |
| 80053 Clinical Chemistry | Office | 1,567 | 207 | $10.34 | $16K |
| 83615 Clinical Chemistry | Office | 1,521 | 207 | $5.92 | $8,999 |
| 83735 Clinical Chemistry | Office | 1,516 | 207 | $6.57 | $9,955 |
| 85025 Blood Count | Office | 1,349 | 198 | $7.61 | $10K |
| 88185 Surgical Pathology Examination | Office | 1,242 | 38 | $18.58 | $23K |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 962 | 19 | $0.23 | $218 |
| 99214 Office E&M - Established | Office | 917 | 199 | $91.73 | $84K |
| 82787 Immunoassay | Office | 717 | 81 | $7.86 | $5,636 |
By year: 2022 $4.9M for 246,560 services; 2023 $4.2M for 195,409 services; 2024 $4.4M for 186,361 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,585 | 210 | $8.65 | $14K |
| 83521 Immunoassay | 1,584 | 104 | $16.92 | $27K |
| 80053 Clinical Chemistry | 1,567 | 207 | $10.34 | $16K |
| 83615 Clinical Chemistry | 1,521 | 207 | $5.92 | $8,999 |
| 83735 Clinical Chemistry | 1,516 | 207 | $6.57 | $9,955 |
| 85025 Blood Count | 1,349 | 198 | $7.61 | $10K |
| 88185 Surgical Pathology Examination | 1,242 | 38 | $18.58 | $23K |
| 82787 Immunoassay | 717 | 81 | $7.86 | $5,636 |
| 85027 Blood Count | 227 | 56 | $6.34 | $1,439 |
| 85007 Blood Count | 226 | 55 | $3.72 | $841 |
Medicare prescription drug claims, 2024
In 2024, the drug Robert B Berryman prescribed most often to Medicare patients was Acyclovir, with 367 prescriptions and refills. In total Robert B Berryman wrote 4,173 Medicare prescriptions that cost $6.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Acyclovir Generic | 367 | 561 | 78 | $4,496 |
| Valacyclovir Valacyclovir Hcl | 283 | 474 | 64 | $12K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 161 | 163 | 38 | $9,312 |
| Potassium Chloride Generic | 122 | 203 | 32 | $3,525 |
| Pantoprazole Sodium Generic | 120 | 208 | 31 | $1,205 |
| Montelukast Sodium Generic | 114 | 276 | 38 | $1,375 |
| Gabapentin Generic | 102 | 139 | 25 | $1,242 |
| Zolpidem Tartrate Generic | 89 | 107 | 13 | $712 |
| Dexamethasone Generic | 84 | 121 | 32 | $1,645 |
| Prednisone Generic | 75 | 117 | 17 | $617 |
| Jakafi Ruxolitinib Phosphate | 74 | 74 | 11 | $1.3M |
| Amlodipine Besylate Generic | 74 | 187 | 25 | $399 |
| Alprazolam Generic | 68 | 69 | 15 | $940 |
| Ondansetron Odt Ondansetron | 68 | 70 | 36 | $894 |
| Methylprednisolone Generic | 61 | 61 | 36 | $358 |
Brand drugs: 599 claims; generic drugs: 3,560 claims; opioid claims: 311.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Robert B Berryman $21K ($21K in general payments such as food, travel and fees) from 29 companies. The largest payer was E.R. Squibb & Sons, L.L.C. with $13K.
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. BMY | 6 | $13K |
| Karyopharm Therapeutics Inc. KPTI | 10 | $3,728 |
| Abbvie Inc. ABBV | 7 | $3,363 |
| Incyte Corporation INCY | 5 | $197 |
| Astellas Pharma US Inc 4503.T | 3 | $92.46 |
| GlaxoSmithKline, LLC. GSK | 4 | $92.02 |
| Sanofi-Aventis U.S. LLC SNY | 2 | $80.05 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 3 | $69.89 |
| Alexion Pharmaceuticals, Inc. AZN | 2 | $63.68 |
| Janssen Biotech, Inc. JNJ | 2 | $61.04 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.